Table 3 Incidence of adverse events that caused discontinuation of treatment
Adverse events (n = 40) | Incidence of occurrence, n (%) |
|---|---|
Laboratory abnormality | 16 (40) |
Descompensated cirrhosis (ascites/encephalopathy) | 7 (17.5) |
Incapacitating symptoms | 4 (10) |
Acute Renal Failure | 3 (7.5) |
Psoriasis | 1 (2.5) |
Diagnosis of Hepatocellular carcinoma | 1 (2.5) |
Death | 8 (20) |